1. Home
  2. SLVM vs AAPG Comparison

SLVM vs AAPG Comparison

Compare SLVM & AAPG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Sylvamo Corporation

SLVM

Sylvamo Corporation

HOLD

Current Price

$38.58

Market Cap

1.7B

ML Signal

HOLD

AAPG

Ascentage Pharma Group International American Depository Shares

HOLD

Current Price

$20.14

Market Cap

2.0B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
SLVM
AAPG
Founded
1898
2009
Country
United States
China
Employees
N/A
767
Industry
Paper
Biotechnology: Pharmaceutical Preparations
Sector
Basic Materials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.7B
2.0B
IPO Year
2021
N/A

Fundamental Metrics

Financial Performance
Metric
SLVM
AAPG
Price
$38.58
$20.14
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
3
5
Target Price
$54.00
$48.40
AVG Volume (30 Days)
312.4K
16.2K
Earning Date
05-08-2026
05-20-2026
Dividend Yield
4.15%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$3,351,000,000.00
N/A
Revenue This Year
$0.93
$290.34
Revenue Next Year
$1.54
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$35.53
$16.36
52 Week High
$56.80
$48.45

Technical Indicators

Market Signals
Indicator
SLVM
AAPG
Relative Strength Index (RSI) 47.08 48.73
Support Level $36.87 $18.56
Resistance Level $43.60 $27.98
Average True Range (ATR) 1.48 0.67
MACD 0.04 0.24
Stochastic Oscillator 43.81 47.38

Price Performance

Historical Comparison
SLVM
AAPG

About SLVM Sylvamo Corporation

Sylvamo Corp is an uncoated papers company with a broad portfolio of top-tier brands and low-cost, large-scale paper mills. It produces uncoated freesheet (UFS) for paper products such as cut size and offset paper, as well as market pulp. The company offers Copy and Printer papers, Commercial Printing papers, Converting papers, and Specialty papers. It operates in three geographical segments: Europe, Latin America, and North America. Key revenue is generated from North America.

About AAPG Ascentage Pharma Group International American Depository Shares

Ascentage Pharma Group International is a clinical-stage biotechnology company engaged in the development and sales of novel small-scale therapies for cancers, hepatitis B virus, or HBV, and certain age-related diseases. It focuses on developing therapies that inhibit protein-protein interactions to restore apoptosis or programmed cell death. The Group has one reportable operating segment, which is discovering, developing, and commercializing therapies to address medical needs in hematological malignancies and currently has seven drug candidates in pipeline under research. The company's geographical segments include the United States and Mainland China.

Share on Social Networks: